PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.84%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
2.67%
Positive gross profit growth while MTDR is negative. John Neff would see a clear operational edge over the competitor.
4.38%
Positive EBIT growth while MTDR is negative. John Neff might see a substantial edge in operational management.
4.38%
Positive operating income growth while MTDR is negative. John Neff might view this as a competitive edge in operations.
-63.06%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-63.64%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-63.20%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-2.03%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.56%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-51.01%
Dividend reduction while MTDR stands at 0.08%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-15.63%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-565.57%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-42.08%
Negative 10Y revenue/share CAGR while MTDR stands at 690.14%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-42.08%
Negative 5Y CAGR while MTDR stands at 1272.50%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-42.08%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-33.38%
Negative 10Y net income/share CAGR while MTDR is at 163.75%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-33.38%
Negative 5Y net income/share CAGR while MTDR is 139.65%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-33.38%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
75.99%
Below 50% of MTDR's 274.37%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
75.99%
Below 50% of MTDR's 204.54%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
75.99%
3Y equity/share CAGR at 50-75% of MTDR's 101.40%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-27.31%
Firm’s AR is declining while MTDR shows 2.38%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
59.61%
Inventory growth well above MTDR's 23.07%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.67%
Similar asset growth to MTDR's 1.79%. Walter Schloss finds parallel expansions or investment rates.
-0.99%
We have a declining book value while MTDR shows 2.09%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
13.61%
Debt growth far above MTDR's 0.54%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-2.69%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.